MedTrace Logo

Active Pauses for Musculoskeletal Disorder Prevention in Workers

NCT07417527 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-02-19

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if short exercise breaks at work can prevent muscle and joint pain in workers. The main questions it aims to answer are:

Do strength exercises help workers move better and feel less pain?

Are strength exercises better than stretching exercises for worker health?

Researchers will compare a strength exercise program to a mobility (stretching) program to see which one works better to improve physical health and work ability.

Participants will:

Perform short exercise breaks (5 minutes) at their workplace every day for 8 weeks.

Attend one supervised session per week to learn the exercises.

Complete simple physical tests (like standing up from a chair) and answer surveys about their health at the start and end of the study.

Conditions

  • Musculoskeletal Disorders (MSDs)
  • Occupational Diseases
  • Sedentary Behaviors
  • Prevention

Interventions

BEHAVIORAL

Strength Active Pause

High-intensity interval training protocol using resistance exercises (elastic bands) performed at the workplace.

BEHAVIORAL

Mobility Active Pause

Standard routine of articular mobility and static stretching exercises performed at the workplace.

Sponsors & Collaborators

  • University of the Basque Country (UPV/EHU)

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-07-31
Completion
2029-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07417527 on ClinicalTrials.gov